Regen BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	0	1	1	6	33	130
Market Cap Growth	-87.23%	-48.33%	-83.75%	-80.65%	-74.88%	59229.10%
Enterprise Value	1	2	2	7	34	132
Last Close Price	0.00	0.01	0.10	0.90	4.88	22.82
PE Ratio	-	-	-	6.18	14.69	-
PS Ratio	0.83	2.25	4.35	26.75	138.87	760.54
PB Ratio	-0.03	-0.08	-0.20	-1.24	-4.07	-9.65
EV/Sales Ratio	5.37	6.62	7.13	29.34	145.32	773.60
Debt / Equity Ratio	-0.16	-0.19	-0.15	-0.15	-0.16	-0.27
Net Debt / Equity Ratio	-0.16	-0.18	-0.15	-0.12	-0.15	-0.21
Asset Turnover	1.10	1.09	0.92	0.52	0.27	0.26
Quick Ratio	0.04	0.04	0.02	0.02	0.04	0.06
Current Ratio	0.04	0.04	0.03	0.03	0.04	0.07
Return on Assets (ROA)	-241.77%	-97.12%	-101.33%	-94.09%	-23.97%	-18.79%
Return on Capital Employed (ROCE)	12.60%	5.40%	8.00%	13.90%	4.20%	1.50%
Earnings Yield	-883.67%	-239.77%	-64.96%	18.27%	7.47%	-5.20%
Buyback Yield / Dilution	-536.19%	-186.14%	-16.21%	-12.79%	-56.19%	-113.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.